# Ponce Financial Group, Inc.: overview

PDLB · Nasdaq · CIK 1874071 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pdlb.md) · [Financials](/companies/pdlb/financials.md) · [Filings](/companies/pdlb/filings.md) · [Insiders](/companies/pdlb/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [0.10](/filings/0001193125-25-267220.md) | not reported | [0.25](/filings/0001193125-26-209832.md) | [0.25](/filings/0001193125-26-334218.md) | [0.27](/filings/0001193125-25-267220.md) | not reported | [0.36](/filings/0001193125-26-209832.md) | [0.35](/filings/0001193125-26-334218.md) |
| Free cash flow | $m | [(15.0) d](/filings/0001193125-25-267220.md) | [22.4 d](/filings/0001193125-26-104610.md) | [12.9](/filings/0001193125-26-209832.md) | [5.9 d](/filings/0001193125-26-334218.md) | [0.8 d](/filings/0001193125-25-267220.md) | [34.9 d](/filings/0001193125-26-104610.md) | [13.8](/filings/0001193125-26-209832.md) | [8.0 d](/filings/0001193125-26-334218.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [1.51](/filings/0000950170-24-033436.md) | [(1.32)](/filings/0000950170-25-038826.md) | [0.15](/filings/0001193125-26-104610.md) | [0.46](/filings/0001193125-26-104610.md) | [1.20](/filings/0001193125-26-104610.md) |
| Free cash flow | $m | [14.4](/filings/0000950170-24-033436.md) | [9.3](/filings/0000950170-25-038826.md) | [6.1](/filings/0001193125-26-104610.md) | [4.5](/filings/0001193125-26-104610.md) | [54.6](/filings/0001193125-26-104610.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/pdlb/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $34.6m | 1,735,395 |  | Added +113,644 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $19.0m | 954,536 |  | Added +15,436 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $17.5m | 877,782 |  | Added +7,416 |
| [BANK OF AMERICA CORP /DE/](/funds/70858.md) | 2026-06-30 | $10.1m | 508,102 |  | Added +3,544 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $9.9m | 496,282 |  | Added +32,967 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $7.6m | 380,812 |  | Added +41,893 |
| [ALLIANCEBERNSTEIN L.P.](/funds/1109448.md) | 2026-06-30 | $6.0m | 358,482 |  | Added +69,450 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $4.7m | 234,908 |  | Added +192,014 |
| [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $4.6m | 231,135 |  | Reduced −11,000 |
| [MANGROVE PARTNERS IM, LLC](/funds/1535392.md) | 2026-06-30 | $3.8m | 191,343 |  | Unchanged |

## Recent filings

[All 211 filings](/companies/pdlb/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-05 | 10:53 ET | [10-Q](/filings/0001193125-26-334218.md) | Quarterly report, period 2026-06-30 | 0001193125-26-334218 |
| 2026-07-27 | 07:26 ET | [8-K](/filings/0001193125-26-316826.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-316826 |
| 2026-06-12 | 11:26 ET | [8-K](/filings/0001193125-26-268852.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-268852 |
| 2026-05-07 | 21:08 ET | [10-Q](/filings/0001193125-26-209832.md) | Quarterly report, period 2026-03-31 | 0001193125-26-209832 |
| 2026-04-24 | 07:34 ET | [8-K](/filings/0001193125-26-174984.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-174984 |
| 2026-04-22 | 08:40 ET | [DEF 14A](/filings/0001193125-26-168750.md) | Proxy statement, period 2026-06-11 | 0001193125-26-168750 |
| 2026-03-31 | 18:01 ET | [8-K](/filings/0001193125-26-132287.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-132287 |
| 2026-03-13 | 18:56 ET | [10-K](/filings/0001193125-26-104610.md) | Annual report, period 2025-12-31 | 0001193125-26-104610 |
| 2026-01-27 | 17:09 ET | [8-K](/filings/0001193125-26-024843.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-024843 |
| 2025-11-05 | 17:07 ET | [10-Q](/filings/0001193125-25-267220.md) | Quarterly report, period 2025-09-30 | 0001193125-25-267220 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-104610.md), filed Mar 13, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1874071
- Tickers: PDLB
- Exchange: Nasdaq
- SIC code: 6035 Savings Institution, Federally Chartered
- State of incorporation: MD
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 09:26 ET. No prices; not investment advice.